Trusts($TRSTS)


Group Portfolio

-

Trusts($TRSTS) > T5 slip for interest never received > CLXN - News - Strong Buy - CLX Medical, Inc. Files View modes: 
  • CLXN - News - Strong Buy - CLX Medical, Inc. Files

    - |
    User avatar
    0 stars

    CLXN - News - Strong Buy - CLX Medical, Inc. Files Form 8-K on Definitive Agreement for the Acquisition of the ThyroTest(R) Rapid Screening Device

    2008-09-17 10:02 ET - News Release

    MURRIETA, CA -- (MARKET WIRE) -- 09/17/08

    CLX Medical, Inc. (OTCBB: CLXN), which is focused on the marketing and distribution of unique medical diagnostic testing products, has filed a Current Report on Form 8-K regarding its planned purchase of ThyroTest®, a rapid thyroid stimulating hormone (TSH) screening device used for the detection of hypothyroidism in adults, a common thyroid disease.

    The Form 8-K can be accessed through a link to SEC filings in the "Corporate" section of the CLX Medical website, www.clxmedical.com.

    The Form 8-K reports that on September 9, 2008, CLX Medical entered into a product purchase agreement with ThyroTec, LLC, the developer of the ThyroTest® device, pursuant to which CLX Medical will acquire from ThryoTec the exclusive, worldwide rights to ThyroTest®, together with related packaging and marketing materials. The purchase price for the acquisition consists of a cash payment of $750,000 upon closing and the issuance of Series C convertible preferred stock of CLX Medical convertible into fifteen percent (15%) of the total, fully-diluted common stock of the company.

    Upon closing, Jim Small, ThyroTec's chief executive officer, or his designate will be appointed as a member of CLX Medical's board of directors. Mr. Small has 30 years of thyroid related pharmaceutical experience and is the co-founder of ThyroTec. A detailed biography of Mr. Small will



    http://investorshub.advfn.com/boards/board.aspx?board_id=4344


    Rate this post
    0 stars
    v
    Usefulness

    Clarity

    Credibility